热门搜索: 论文 发表 社科期刊 北大核心 南大核心 cssci 科技期刊 教育

当前位置:主页 > 医学论文 > 药学论文 >

RGD肽修饰的聚谷氨酸-顺铂复合物的体外评价

发布时间:2019-02-16 08:21  文章来源:笔耕文化传播
【摘要】:目的:本研究以经柠檬酸改性的聚谷氨酸为载体,制备聚谷氨酸-顺铂复合物,接枝环RGD肽,以提高该复合物对肿瘤细胞的靶向性,同时对所得到的高分子-药物复合物体外理化性质和细胞毒作用、细胞摄取进行评价。方法:以改性聚谷氨酸侧链羧基与顺铂稳定配位,再与RGD肽进行化学偶联,得到修饰后的药物复合物,对复合物的载药量等性质进行了考察,同时采用人乳腺癌MDA-MB-231细胞和MCF-7细胞进行了体外细胞生长抑制和细胞摄取行为的评价。结果:与未修饰的聚合物-药物复合物(23.12%)比较,本研究所制备主动靶向聚谷氨酸-顺铂复合物的载药量略有下降(16.73%),体外释放参数无显著差异,表现出明显的缓释特征。体外细胞毒实验结果表明,两类复合物保留了顺铂对肿瘤细胞的毒性,相比无RGD修饰的复合物,人乳腺癌MDA-MB-231和MCF-7细胞对RGD修饰的复合物摄取增强。结论:RGD修饰的顺铂-聚谷氨酸复合物成功制备,有利于提高针对体内肿瘤的缓释、靶向治疗效果。
[Abstract]:Aim: to prepare polyglutamic acid-cisplatin complex with citric acid modified polyglutamic acid as carrier and graft cyclic RGD peptide to improve its targeting to tumor cells. At the same time, the physicochemical properties, cytotoxicity and cellular uptake of the polymer-drug complexes in vitro were evaluated. Methods: the modified poly (glutamic acid) side chain carboxyl group was stably coordinated with cisplatin, then chemically coupled with RGD peptide to obtain the modified drug complex. Human breast cancer MDA-MB-231 cells and MCF-7 cells were used to evaluate cell growth inhibition and cell uptake in vitro. Results: compared with unmodified polymer-drug complexes (23.12%), the amount of active target polyglutamic acid-cisplatin complexes was slightly decreased (16.73%), and there was no significant difference in vitro release parameters. It shows obvious slow release characteristics. The results of cytotoxicity test in vitro showed that the two kinds of complexes retained the toxicity of cisplatin to tumor cells. Compared with the complexes without RGD modification, the uptake of RGD modified complexes by MDA-MB-231 and MCF-7 cells of human breast cancer increased. Conclusion: the successful preparation of RGD modified cisplatin-polyglutamic acid complex is beneficial to improve the sustained release and target therapeutic effect of tumor in vivo.
【作者单位】: 中国药科大学药学院;
【基金】:中央高校基本科研业务费科研专项基金(ZJ14141)
【分类号】:R943;R96

【参考文献】

相关期刊论文 前1条

1 胡秀丽;谢志刚;黄宇彬;景遐斌;;高分子药物学的研究进展与期盼[J];高分子学报;2013年06期

【共引文献】

相关期刊论文 前10条

1 李贵平;张辉;池晓华;黄凯;;多肽受体介导的放射性核素靶向治疗的研究进展(文献综述)[J];放射免疫学杂志;2010年03期

2 闫强;赵越;;二氧化碳响应性聚合物及其应用进展[J];高分子材料科学与工程;2014年02期

3 孙博薇;王伟;曹延武;刘瑞红;赵燕军;王征;;热响应纳米金球作为非共价药物载体合成及性质研究[J];高分子学报;2014年05期

4 刘东红;丁建勋;许维国;宋晓峰;庄秀丽;陈学思;;四臂聚乙二醇-聚丙交酯立体复合胶束及其药物传输性能[J];高分子学报;2014年09期

5 Yan Zhang;Xiao-ju Wang;Miao Guo;阎虎生;Chen-hong Wang;刘克良;;Cisplatin-loaded Polymer/Magnetite Composite Nanoparticles as Multifunctional Therapeutic Nanomedicine[J];Chinese Journal of Polymer Science;2014年10期

6 Yi-fei Li;Hai-yang Yu;Hai Sun;刘建国;汤朝晖;Dan Wang;Lian-you Yu;Xue-si Chen;;Cisplatin-loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Nanoparticles as a Potential Chemotherapeutic Agent against Osteosarcoma[J];Chinese Journal of Polymer Science;2015年05期

7 闫丹;郭慧琛;冯霞;靳野;魏衍全;孙世琪;;口蹄疫病毒样颗粒作为抗癌药物载体的条件探索[J];安徽农业科学;2015年13期

8 ;Radiolabeling and evaluation of ~(188)Re-RGD as an agent for α_vβ_3 receptor expression[J];Nuclear Science and Techniques;2012年01期

9 马玉飞;于俊峰;周伟;沈华;胡伟青;尹端l,

本文编号:2424244


论文下载
论文发表
教材专著
专利申请


    下载步骤:1.微信扫码,备注编号 2424244. 2.自助下载


    本文链接:http://www.bigengculture.com/yixuelunwen/yiyaoxuelunwen/2424244.html